lung cancer Archives | Be Korea-savvy
New Global Survey Shows Misperceptions About Lung Cancer Among the General Public

New Global Survey Shows Misperceptions About Lung Cancer Among the General Public

LONDON, Nov. 27 (Korea Bizwire) — Only one in five people (22%) disagree with the statement “generally, patients with lung cancer have caused their illness through their lifestyle choices and behaviors,” according to a global, omnibus survey conducted by Ipsos MORI and sponsored by the Lung Ambition Alliance. The results were released to coincide with the [...]

Lung Ambition Alliance Unveils New Initiatives to Address Lung Cancer Survival at the World Conference on Lung Cancer

Lung Ambition Alliance Unveils New Initiatives to Address Lung Cancer Survival at the World Conference on Lung Cancer

BARCELONA, Spain, Sept. 7 (Korea Bizwire) — Today, at the IASLC World Conference on Lung Cancer, the four founding partners of the Lung Ambition Alliance – the International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) and AstraZeneca – announced the launch of several new initiatives to [...]

Lung Ambition Alliance Launches with Goal to Double Five-year Survival in Lung Cancer by 2025

Lung Ambition Alliance Launches with Goal to Double Five-year Survival in Lung Cancer by 2025

LONDON, Jul. 8 (Korea Bizwire) — Today, the International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) and AstraZeneca announced the Lung Ambition Alliance, a new partnership with a bold ambition to eliminate lung cancer as a cause of death. The first goal of the Alliance will [...]

World Conference on Lung Cancer Wednesday Press Conference: Applying Conference Discoveries and Themes to the Real World

World Conference on Lung Cancer Wednesday Press Conference: Applying Conference Discoveries and Themes to the Real World

TORONTO, Sept. 26 (Korea Bizwire) — The final press briefing from the International Association for the Study of Lung Cancer’s (IASLC’s) 19th World Conference on Lung Cancer (WCLC) was led by conference co-presidents Natasha B. Leighl, M.D., BSc, MSc, and Gail Darling M.D., FRCSC, who reviewed the innovative work in lung cancer research and treatment [...]

World Conference on Lung Cancer Tuesday Press Conference: Improving the Cure Rate for Stage III Lung Cancer

World Conference on Lung Cancer Tuesday Press Conference: Improving the Cure Rate for Stage III Lung Cancer

TORONTO, Sept. 25 (Korea Bizwire) — Today’s press conference at the International Association for the Study of Lung Cancer’s (IASLC’s) 19th World Conference on Lung Cancer (WCLC) featured some of the year’s most innovative research in both small cell and non-small cell lung cancer. Frances Shepherd, M.D., FRCPC, WCLC honorary chair, medical oncologist at Princess [...]

World Conference on Lung Cancer Monday Press Conference: Clinical Research Results and Gender Differences in Lung Cancer Survival

World Conference on Lung Cancer Monday Press Conference: Clinical Research Results and Gender Differences in Lung Cancer Survival

TORONTO, Sept. 24 (Korea Bizwire) — At today’s press conference at the International Association for the Study of Lung Cancer’s (IASLC’s) 19th World Conference on Lung Cancer (WCLC), conference co-president Dr. Andrea Bezjak, M.D., FRCPC, MSc, professor in the Departments of Radiation Oncology and Health Policy, Management and Evaluation at the University of Toronto and [...]

Researchers, Survivors, Advocates and Physicians Convene to Discuss Innovations in Lung Cancer Research, Treatment and Advocacy at the Largest-Attended World Conference on Lung Cancer

Researchers, Survivors, Advocates and Physicians Convene to Discuss Innovations in Lung Cancer Research, Treatment and Advocacy at the Largest-Attended World Conference on Lung Cancer

TORONTO, Sept. 23 (Korea Bizwire) — Patients, survivors and advocates joined researchers and physicians from across the globe to discuss the future of lung cancer at the International Association for the Study of Lung Cancer’s (IASLC’s) 19th World Conference on Lung Cancer (WCLC) in Toronto, Canada. The conference’s first press briefing highlighted the record-breaking number [...]

The IASLC 19th World Conference on Lung Cancer Arrives in Toronto, Canada

The IASLC 19th World Conference on Lung Cancer Arrives in Toronto, Canada

DENVER, Aug. 21 (Korea Bizwire) – What: The International Association for the Study of Lung Cancer (IASLC) presents the IASLC 19th World Conference on Lung Cancer (WCLC) on September 23-26, 2018, in Toronto, Canada. The WCLC is the world’s largest meeting dedicated solely to lung cancer and other thoracic malignancies, and is expected to convene over 7,000 [...]

Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer

Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer

NEW YORK, Aug. 13 (Korea Bizwire) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that preliminary safety and efficacy data from a Phase 1/2 clinical trial of CK-101 (also known as RX518), a [...]